Bart Classen, M.D.

Chief Scientific Officer, 617-532-6410
Bart Classen has had experience working in both the pharmaceutical and securities industries. For the majority of years from 1991-2005 Bart was a biopharmaceutical consultant/analyst working with the Perceptive Life Science Fund, Paramount Capital Asset Management, and Prudential Securities. The remainder of Dr. Classen’s time was spent working in the pharmaceutical industry, having started a small biopharmaceutical company in 1991 focused on vaccine and pharmaceutical safety and holding numerous patents on the technology. He received his MD from the University of Maryland, his MBA from Columbia University, and performed a three-year fellowship at NIH.